Table 2.
Cervical cancer member characteristics by stage, diagnosed 2016–2020 (N = 1,866)
| Stage | I | II | III | IV |
|---|---|---|---|---|
| n (%)a, b | 1,300 (69.7%) | 198 (10.6%) | 215 (11.5%) | 153 (8.2%) |
| Age, mean (SD), yearsb | 58.6 (12.3) | 57.5 (12.1) | 60.4 (12.2) | 59.9 (12.7) |
| Female Gender, n (%)b | 1300 (100.0%) | 198 (100.0%) | 215 (100.0%) | 153 (100.0%) |
| Insurance Type, n (%)a, b | ||||
| Commercial | 97 (49.0%) | 92 (42.8%) | 73 (47.7%) | 97 (49.0%) |
| Medicaid | 27 (13.6%) | 14 (6.5%) | 14 (9.2%) | 27 (13.6%) |
| Medicare Advantage | 54 (27.3%) | 82 (38.1%) | 52 (34.0%) | 54 (27.3%) |
| Multiplec | 0 (0.0%) | 1 (0.5%) | 0 (0.0%) | 0 (0.0%) |
| Unknown | 20 (10.1%) | 26 (12.1%) | 14 (9.2%) | 20 (10.1%) |
| Geographic Region, n (%)a, b | ||||
| Midwest | 578 (44.5%) | 87 (43.9%) | 84 (39.1%) | 65 (42.5%) |
| Northeast | 484 (37.2%) | 64 (32.3%) | 76 (35.4%) | 50 (32.7%) |
| South | 114 (8.8%) | 33 (16.7%) | 32 (14.9%) | 15 (9.8%) |
| West | 104 (8.0%) | 12 (6.1%) | 18 (8.4%) | 18 (11.8%) |
| Unknown | 20 (1.5%) | 2 (1.0%) | 5 (2.3%) | 5 (3.3%) |
| CCI, mean (SD)d | 0.8 (1.2) | 0.8 (1.3) | 1.3 (1.7) | 1.3 (1.6) |
| CCI, n (%)a, d | ||||
| 0 | 447 (57.2%) | 56 (57.7%) | 42 (43.8%) | 27 (36.5%) |
| 1 | 192 (24.6%) | 21 (21.6%) | 21 (21.9%) | 24 (32.4%) |
| 2 | 81 (10.4%) | 10 (10.3%) | 13 (13.5%) | 12 (16.2%) |
| ≥ 3 | 62 (7.9%) | 10 (10.3%) | 20 (20.8%) | 11 (14.9%) |
Charlson Comorbidity Index; SD Standard deviation
a Percentages may not total to 100% due to rounding
b Demographics were calculated at the time of cancer diagnosis
c Individuals had insurance eligibility from multiple types during this period
d CCI was calculated among subjects with 6 months of continuous insurance eligibility prior to their cancer diagnosis